Milnacipran hydrochloride and Sleep disorder - a phase IV clinical study of FDA data

Summary:

Sleep disorder is reported only by a few people who take Milnacipran Hydrochloride.

The phase IV clinical study analyzes which people take Milnacipran hydrochloride and have Sleep disorder. It is created by eHealthMe based on reports of 458 people who have side effects while taking Milnacipran hydrochloride from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 21, 2023

458 people reported to have side effects when taking Milnacipran hydrochloride.
Among them, 3 people (0.66%) have Sleep disorder.

What is Milnacipran hydrochloride?

Milnacipran hydrochloride has active ingredients of milnacipran hydrochloride. eHealthMe is studying from 385 Milnacipran hydrochloride users for its effectiveness, alternative drugs and more.

What is Sleep disorder?

Sleep disorder is found to be associated with 3,340 drugs and 2,807 conditions by eHealthMe.

Number of Milnacipran hydrochloride and Sleep disorder reports submitted per year:

Could Milnacipran hydrochloride cause Sleep disorder?

Gender of people who have Sleep disorder when taking Milnacipran hydrochloride *:

female: 0.0 %
male: 100 %

Age of people who have Sleep disorder when taking Milnacipran hydrochloride *:

Common drugs people take besides Milnacipran hydrochloride *:

Common side effects people have besides Sleep disorder *:

Suicide Attempt: 3 people, 100.00%
Suicidal Ideation: 3 people, 100.00%
Depression: 3 people, 100.00%
Stress And Anxiety: 2 people, 66.67%
Feeling Abnormal: 2 people, 66.67%
Chest Pain: 2 people, 66.67%
Agitation (state of anxiety or nervous excitement): 2 people, 66.67%
Renal Impairment (severely reduced kidney function): 1 person, 33.33%
Overdose: 1 person, 33.33%

Common conditions people have *:

Depression: 3 people, 100.00%
Hiv Infection: 2 people, 66.67%

* Approximation only. Some reports may have incomplete information.

Do you take Milnacipran hydrochloride and have Sleep disorder?

Check whether Sleep disorder is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Lin SC, Su YC, Huang YS, Lee CC, "Zolpidem increased cancer risk in patients with sleep disorder: A 3-year follow-up study", Journal of Medical Sciences, 2016 Mar .

Related studies

Sleep disorder treatments and more:

Sleep disorder (156,400 reports)

COVID vaccines that are related to Sleep disorder:

Common drugs associated with Sleep disorder:

All the drugs that are associated with Sleep disorder:

Sleep disorder (3,340 drugs)

Common conditions associated with Sleep disorder:

Rheumatoid arthritis: 6,698 reports
Asthma: 6,129 reports
Depression: 4,795 reports
Pain: 4,068 reports
High blood pressure: 3,039 reports

All the conditions that are associated with Sleep disorder:

Sleep disorder (2,807 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on milnacipran hydrochloride (the active ingredients of Milnacipran hydrochloride) and Milnacipran hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.